HEATHER SHAH: Open Payments
NPI 1598523326 · VERNON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,792 in 88 payments from 23 companies in 2025. Trend: 2023 $19 · 2024 $609 · 2025 $1,792
Food & beverage: $1,725Education: $67
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 38 | $465 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $214 |
| AstraZeneca Pharmaceuticals LP | 7 | $201 |
| Viatris Specialty LLC | 4 | $101 |
| Verona Pharma, Inc. | 4 | $93 |
| Amgen Inc. | 3 | $76 |
| SANOFI-AVENTIS U.S. LLC | 1 | $67 |
| Insmed, Inc. | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 3 | $58 |
| INOGEN, INC. | 2 | $51 |
Products named: NUCALA, TRELEGY ELLIPTA, GLASSIA, TEZSPIRE, DUPIXENT, AIRSUPRA, YUPELRI, Ohtuvayre.
Industry payments across CT — which companies pay providers there.
